Events

Keep up to date with conferences, meetings

and every important event with the amc

The Advanced therapy medicinal products Manufacturing Community

The latest meetings, conferences, exhibitions and more

28th Technical Meeting

Industry’s response to the changing market needs of CGT

The day will include a combination of specialised talks on this theme, a choice of workshops and a ’round table’ session. There will also be a number of opportunities for networking and discussions with vendors.

Agenda

08:00
Registration and Networking

08:30
Introduction and amc update

Full Accounts, 07 Nov 2024 AGM Minutes, 02 Oct 2025 Board Agenda Minutes

 

09:00 Session 1.
What challenges do today’s spin outs really face? Mike Delahaye

  • From Breakthroughs to Breakdowns: Rethinking the Spin-Out Model – Chris Green, Cell Rev (click for PDF)
  • Development of allogenic cell therapy- where do we stand? – Pete Tonge, ex Bit BIO
  • Behind the Spinout: The Hurdles of Starting Up in Biotech, A Biotech’s Tale of Trals, Translation and Tenacity – Kayleigh Thirwell, Resolution (click for PDF)
  • Investing into the next generation of CGTC start-ups – Kerstin Papenfuss, Deep Science Ventures (click for PDF)
  • Beccy Gavin, Evox (click for PDF)

11.25
(Tea/Coffee) touch

11.55  Session 2.
How are the regulators adapting to support UK CGTs? Ruxandra Comisel

  • The Obstacle is the Way: How UK Regulators Transform Cell and Vector Challenges into Pathways – Owen Bain, Royal Free (click for PDF)
  • Harriet Edwards, Boyd Consultants
  • Tish Kanwarjit, Autolus (click for PDF)
12.55

Lunch

13.55 Session 3.
How is UK manufacturing responding to the changing needs of CGT? Abby Clark

  • Responding to the Changing Needs of CGT – Lucy Foley, eXmoor Pharma
  • Stephen Ward, Cell and Gene Therapy Catapult (click for PDF)
  • Enabling Advanced Therapy Manufacture: The NHS as a Critical Link – Paul Lloyd-Evans, NHSBT

15.15
Tea/Coffee

15.40 Supplier Pitch – Fresenius Kabi

15.45 Panel Session.
Derisking CGTs for investment, Michael Whitaker
Shailesh Maingi (Kineticos Ventures), Kerstin Papenfuss (Deep Science Ventures), Pete Tonge (ex Bit BIO), Jan Thirkettle (Harness Therapeutics)

17:00
Close

Supper

image

For those of you who are joining us for dinner, we are eating at cinnabar

1800

cinnabar
View on map

Sponsors

  • Azenta Life Sciences
    Azenta Life Sciences

    Azenta Life Sciences is a global leader in cryogenic storage and sample management, supporting the unique needs of cell and gene therapy innovators.

    Our state-of-the-art biorepositories and automated storage systems are designed to safeguard the integrity, quality, and traceability of critical samples at every stage of development. With industry-leading expertise in cryogenic cold chain solutions, we help organizations minimize risk, maintain compliance, and ensure that irreplaceable materials are securely preserved and always accessible.

    By delivering scalable and reliable solutions, Azenta empowers researchers and developers to focus on advancing groundbreaking therapies and accelerating their path to patients.

    https://web.azenta.com/cell-and-gene-therapy

  • Fresenius Kabi
    Fresenius Kabi

    At Fresenius Kabi, we support healthcare providers with life-saving medicines and technologies. Together, we are continuously working to find answers to patients’ challenges. Our medical technologies are designed to help make complex therapies simpler and safer while breaking new ground.

    We support healthcare professionals to provide patients with the best possible care. With our comprehensive products and expertise, we facilitate a solid foundation for the highest quality care and recovery. We’ve been passionately committed to improving worldwide healthcare for many years with our pioneering medical technology solutions.

    Our integrated solutions enable better equipment usage and management and, thanks to advanced connectivity, offer simple and effective data management with state-of-the-art software. We work closely with experts and users in different countries to understand their diverse priorities. Our products and services are used by medical professionals across the care continuum – from research labs and blood and plasma collection centres to hospitals, long-term care facilities, alternate care sites, clinics, and homes.

    www.fresenius-kabi.com/gb

  • Radix Partners
    Radix Partners
    At Radix Partners, we specialise in advanced therapies, helping companies navigate the complexities of scalable supply chains and optimise business operations for sustainable growth.
    With a deep understanding of the unique challenges in the field, including hands-on experience in complex commercial models we provide strategic and tactical consultancy services that help streamline operations, optimise and evolve supply chains, reduce costs and drive business growth at every stage.
    As enablers of progress, we partner with visionary biotech companies, manufacturers, distributors, and suppliers to unlock the full operational value chain, enabling the rapid delivery of advanced therapies to patients in need. We believe that a strategic, scalable, and modular supply chain model is critical to accelerating the delivery of these therapies that also provides a clear competitive advantage.

    www.radix.partners/services

     

  • Cell and Gene Therapy Catapult
    Cell and Gene Therapy Catapult

    The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector.

    With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation. The Cell and Gene Therapy Catapult works with Innovate UK. For more information, please visit either:

    ct.catapult.org.uk

    http://www.gov.uk/innovate-uk.

  • bioMérieux
    bioMérieux

    To protect patients, provide safe products and minimise vein to vein time, cutting-edge cellular therapies need state-of-the-art quality control solutions.

    bioMérieux’s proven portfolio of microbiology testing solutions enable sites to carry out tests throughout each stage of the production process. bioMérieux provides solutions adapted for the unique set of requirements for testing ATMP’s. Testing for final products but, also at-line and in-process controls to relieve potential process bottle necks. Helping to maintain regulatory compliance and optimize operations for the future. These include:

    • BACT/ALERT 3D DUAL T: Compendial, rapid and automated sterility testing. Ideally suited for testing turbid, short shelf-life intermediates and final products and reduced vein to vein time.
    • BIOFIRE MYCOPLASMA: A 1 hour test that can be performed at-line, if required. This test can be used for release testing or testing starting materials, culture media and other in-process controls.
    • ENDOZYME II GO SINGLE TEST: An animal-free endotoxin test with in-build controls designed for single or low volume testing.
    • 3P Solutions: This range includes irradiated, plates for environmental monitoring, the AIR IDEAL, active air monitoring system and 3P Software for managing EM campaign in classified areas
    • Accellix: A sister company providing rapid, automated cell attribute testing using innovative flow cytometry technology.

    This is just a snapshot of some of our range, please come and visit our stand to learn more about these and other bioMérieux solutions.

     

    https://www.biomerieux.com/

Feedback form
Delegate List

Time until the next amc Technical Meeting

  • 00 days
  • 00 hours
  • 00 minutes
  • 00 seconds